Search Results - Akhade, Amol

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    To Give or Not to Give Adjuvant Chemotherapy in Breast Cancer? Can CanAssist Breast Assist?

    To Give or Not to Give Adjuvant Chemotherapy in Breast Cancer? Can CanAssist Breast Assist? by Akhade, Amol, Mathew, Aju

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner?

    CDK 4/6 inhibitors for adjuvant therapy in early breast cancer—Do we have a clear winner? by Akhade, Amol, Van Wambeke, Simon, Gyawali, Bishal

    Published in Ecancermedicalscience
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Highlights from Choosing Wisely 2022 for Resource Limited Settings: Reducing Low Value Cancer Care for Sustainability conference, 17th-18th September, Mumbai, India

    Highlights from Choosing Wisely 2022 for Resource Limited Settings: Reducing Low Value Cancer Care for Sustainability conference, 17th-18th September, Mumbai, India by Akhade, Amol, Gyawali, Bishal, Sullivan, Richard, Sirohi, Bhawna

    Published in Ecancermedicalscience
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities

    Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities by West, Howard (Jack), Akhade, Amol, Gyawali, Bishal

    Published in JCO global oncology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Cancer research in lower- and middle-income countries (LMICs): How can we improve?

    Cancer research in lower- and middle-income countries (LMICs): How can we improve? by Akhade, Amol

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC)

    Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC) by Parikh, Purvish M., Vora, Amish, Yadav, Rajan, Kapoor, Akhil, Sahoo, Tarini, Rajappa, Senthil, Kanakashetty, Govind Babu, Krishna, M. Vamshi, Biswas, Ghanashyam, Bahl, Ankur, Ghadyalpatil, Nikhil, Raja, Thirumalairaj, Bajpai, Jyoti, Akhade, Amol, Singh, Randeep, Aggarwal, Shyam, Basade, Maheboob, Advani, S.H.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  7. 7
    Global consequences of the US FDA's accelerated approval of cancer drugs

    Global consequences of the US FDA's accelerated approval of cancer drugs by Akhade, Amol, Sirohi, Bhawna, Gyawali, Bishal

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Arsenic Trioxide (ATO) as Induction Therapy Achieves Early Complete Cytogenetic Remission In Acute Promyelocytic Leukemia (APL)

    Arsenic Trioxide (ATO) as Induction Therapy Achieves Early Complete Cytogenetic Remission In Acute Promyelocytic Leukemia (APL) by Menon, Hari, Akhade, Amol, Sengar, Manju, Amare, Pratibha, Subramanian, P., Nair, Reena, Chougule, Anuradha

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: